October 13, 2022
Share
In the News
Arima Genomics’ customer, Dr. Matija Snuderl of NYU Langone Health, shares how in his pathology lab, where his research focuses on diagnosing and understanding brain tumors, he’s found that using a 3D genomics approach with Hi-C technology can help identify novel clinically actionable aberrations and provide insight into the molecular drivers of brain tumors, which previously had no known drivers.